Gunda I. Georg

11.2k citations

273 papers · 8.0k indexed · 1 hit paper · h-index 43

Co-authors: Richard H. Himes Suzanne B. Buck Sam F. Victory Micah J. Niphakis Ashok Rao Tunoori Jonathan M. White E. Schönbrunn Brandon J. Turunen
Topics: Cancer Treatment and Pharmacology (76 papers)Synthetic Organic Chemistry Methods (56 papers)Microtubule and mitosis dynamics (34 papers)
Cited by: Organic Chemistry Oncology Cell Biology
Journals: Proceedings of the National Academy of Sciences Journal of the American Chemical Society Angewandte Chemie International Edition
Partner nations: United States Germany China

In The Last Decade

Gunda I. Georg

267 papers receiving 7.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Epothilones, a new class of microtubule-stabilizing agents with a taxol-like mechanism of action

1998 811 citations Richard H. Himes, Gunda I. Georg et al. profile →

Peers

Countries citing papers authored by Gunda I. Georg

Since Specialization

Citations

This map shows the geographic impact of Gunda I. Georg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gunda I. Georg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gunda I. Georg more than expected).

Fields of papers citing papers by Gunda I. Georg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gunda I. Georg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gunda I. Georg. The network helps show where Gunda I. Georg may publish in the future.

Co-authorship network of co-authors of Gunda I. Georg

This figure shows the co-authorship network connecting the top 25 collaborators of Gunda I. Georg. A scholar is included among the top collaborators of Gunda I. Georg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gunda I. Georg. Gunda I. Georg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Macrocyclic dihydropyridine analogs as pan-BET BD2-preferred inhibitors 2025 ·European Journal of Medicinal Chemistry ·(unknown),T. Jake Liang,Jonathan Solberg,(unknown),(unknown),Rui Shi,William C. K. Pomerantz,Jon E. Hawkinson,E. Schönbrunn,Gunda I. Georg	0
2	Development of the retinoic acid receptor alpha-specific antagonist YCT-529 for male contraception: A brief review 2025 ·Contraception ·Rui Shi,Debra J. Wolgemuth,Gunda I. Georg	2
3	Pharmacogenomic Synthetic Lethal Screens Reveal Hidden Vulnerabilities and New Therapeutic Approaches for Treatment of NF1-Associated Tumors 2025 ·Molecular Cancer Therapeutics ·Kyle Williams,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Wendy A. Hudson,Gunda I. Georg,Christopher L. Moertel,Nancy Ratner,David A. Largaespada	0
4	Targeting cyclin-dependent kinase 2 (CDK2) interactions with cyclins and Speedy 1 (Spy1) for cancer and male contraception 2025 ·Future Medicinal Chemistry ·Jeanine Giarolla,(unknown),(unknown),(unknown),Bidisha Sarkar,Gunda I. Georg	1
5	Strategies for developing retinoic acid receptor alpha-selective antagonists as novel agents for male contraception 2023 ·European Journal of Medicinal Chemistry ·(unknown),Rebecca A. D. Cuellar,(unknown),Sanny S.W. Chung,(unknown),(unknown),(unknown),(unknown),H.L.S. Wong,E. Schönbrunn,Jon E. Hawkinson,Debra J. Wolgemuth,Gunda I. Georg	7
6	Mitochondria‐targeted metformin (mitomet) inhibits lung cancer in cellular models and in mice by enhancing the generation of reactive oxygen species 2023 ·Molecular Carcinogenesis ·Mohammad Shameem,(unknown),Ali Nakhi,Peter I. Dosa,Gunda I. Georg,Fekadu Kassie	11
7	Development of allosteric and selective CDK2 inhibitors for contraception with negative cooperativity to cyclin binding 2023 ·Nature Communications ·Erik B. Faber,(unknown),(unknown),(unknown),(unknown),Nan Wang,(unknown),(unknown),(unknown),(unknown),An‐Suei Yang,Hira Khalid,Jon E. Hawkinson,Nicholas M. Levinson,Vargheese M. Chennathukuzhi,Daniel A. Harki,E. Schönbrunn,Gunda I. Georg	27
8	Bivalent BET Bromodomain Inhibitors Confer Increased Potency and Selectivity for BRDT via Protein Conformational Plasticity 2022 ·Journal of Medicinal Chemistry ·(unknown),(unknown),(unknown),(unknown),Norbert Berndt,Jun Qi,Gunda I. Georg,E. Schönbrunn	12
9	Discovery and Characterization of Multiple Classes of Human CatSper Blockers 2022 ·ChemMedChem ·(unknown),Rawle Francis,(unknown),(unknown),(unknown),Celia M. Santi,Derek J. Hook,Jon E. Hawkinson,Gunda I. Georg	19
10	The lonidamine derivative H2-gamendazole reduces cyst formation in polycystic kidney disease 2022 ·American Journal of Physiology-Renal Physiology ·(unknown),Julie Zhou,Brenda S. Magenheimer,Gail A. Reif,Darren P. Wallace,Gunda I. Georg,Sudhakar Jakkaraj,Joseph S. Tash,Alan S.L. Yu,Xiaogang Li,James P. Calvet	1
11	Tetrahydroindazole inhibitors of CDK2/cyclin complexes 2021 ·European Journal of Medicinal Chemistry ·(unknown),Kwon Ho Hong,Andreas Becker,Joseph S. Tash,E. Schönbrunn,Gunda I. Georg	6
12	Identification and Screening of Selective WEE2 Inhibitors to Develop Non‐Hormonal Contraceptives that Specifically Target Meiosis 2019 ·ChemistrySelect ·Carol Hanna,Shan Yao,(unknown),E. Schönbrunn,Gunda I. Georg,Jeffrey T. Jensen,Rebecca A. D. Cuellar	7
13	The anti-parasitic agent suramin and several of its analogues are inhibitors of the DNA binding protein Mcm10 2019 ·Open Biology ·(unknown),(unknown),Ryan M. Baxley,Fredy Kurniawan,(unknown),Rawle Francis,Alexandra Sobeck,Brandt F. Eichman,Walter Chazin,Hideki Aihara,Gunda I. Georg,Jon E. Hawkinson,Anja‐Katrin Bielinsky	11
14	Structure–Activity Studies of N‐Butyl‐1‐deoxynojirimycin (NB‐DNJ) Analogues: Discovery of Potent and Selective Aminocyclopentitol Inhibitors of GBA1 and GBA2 2017 ·ChemMedChem ·(unknown),Vijayalaxmi Gupta,(unknown),J. Zhu,(unknown),(unknown),Joseph S. Tash,E. Schönbrunn,Jon E. Hawkinson,Gunda I. Georg	13
15	Regioselective C5-alkylation and C5-methylcarbamate formation of 2,3-dihydro-4-pyridones and C3-alkylation and C3-methylcarbamate formation of 4-(pyrrolidin-1-yl)furan-2(5H)-one 2015 ·Tetrahedron Letters ·(unknown),Gunda I. Georg	5
16	Rapid Delivery of Diazepam from Supersaturated Solutions Prepared Using Prodrug/Enzyme Mixtures: Toward Intranasal Treatment of Seizure Emergencies 2014 ·The AAPS Journal ·Mamta Kapoor,(unknown),Lev Lis,Gunda I. Georg,Ronald A. Siegel	12
17	From HTS to Phase I: The Institute for Therapeutics Discovery and Development at the University of Minnesota 2014 ·Combinatorial Chemistry & High Throughput Screening ·Peter I. Dosa,Gunda I. Georg,(unknown),Jon E. Hawkinson,Michael A. Walters,Henry Ν. C. Wong	3
18	Investigation of 3′-debenzoyl-3′-(3-([124I]-iodobenzoyl))paclitaxel analog as a radio-tracer to study multidrug resistance in vivo 2012 ·Applied Radiation and Isotopes ·M. Arif Sajjad,Ufana Riaz,Rutao Yao,Ralph J. Bernacki,Mohei Abouzied,(unknown),Nilabh Chaudhary,Jean Veith,Gunda I. Georg,(unknown)	2
19	Paclitaxel succinate analogs: Anionic and amide introduction as a strategy to impart blood–brain barrier permeability 2008 ·Bioorganic & Medicinal Chemistry Letters ·Brandon J. Turunen,Haibo Ge,(unknown),Kelly E. Desino,Veena M. Vasandani,(unknown),Richard H. Himes,Kenneth L. Audus,Anna Seelig,Gunda I. Georg	18
20	Mild and Selective Hydrozirconation of Amides to Aldehydes Using Cp₂Zr(H)Cl: Scope and Mechanistic Insight 2007 ·Journal of the American Chemical Society ·Jared T. Spletstoser,Jonathan M. White,Ashok Rao Tunoori,Gunda I. Georg	201

About Gunda I. Georg

Gunda I. Georg is a scholar working on Organic Chemistry, Oncology and Pharmacology, having authored 273 papers that have together received 8.0k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (76 papers), Synthetic Organic Chemistry Methods (56 papers) and Microtubule and mitosis dynamics (34 papers). The work is most often cited by research in Organic Chemistry (4.1k citations), Oncology (2.3k citations) and Cell Biology (1.1k citations). Gunda I. Georg has collaborated with scholars based in United States, Germany and China. Frequent co-authors include Richard H. Himes, Suzanne B. Buck, Sam F. Victory, Micah J. Niphakis, Ashok Rao Tunoori, Jonathan M. White, E. Schönbrunn, Brandon J. Turunen, Mathew P. Martin and Joydeep Kant. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Angewandte Chemie International Edition.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact